We’re delighted to welcome Menarini Pharmaceutical Group, as a partner at this year’s conference edition!

The Menarini Pharmaceutical Group, with headquarters in Florence, is present in 140 countries worldwide to date, with €3.922 billion in revenue and more than 17,000 employees. With 9 centres for Research & Development, Menarini’s products are present in the most important treatment areas: cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesic products. Pharmaceutical production is carried out in the Group’s 18 manufacturing plants, located in Italy and abroad, which produce over 548 million packets of product a year and distribute to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients throughout the world.

You can find out more about the Menarini Pharmaceutical Group by joining FH22 in Milan and online!